1. Ishigami-Yuasa, M., Ekimoto, H., Kagechika, H.. Synergistic inhibition of several human cancer cell proliferations by a synthetic retinoid tamibarotene (Am80) in combination with the epigenetic modulators. FASEB meeting on retinoid Florida, USA

  2. Tsuemoto, N., Mori, S., Kawachi, E., Kagechika, H.. Design and synthesis of novel RAR ligands containing pentafluorosulfanyl group. FASEB meeting on retinoid Florida, USA

  1. Shinya Fujii, Hiroki Saito, Yuichiro Matsumoto, Yuichi Hashimoto, Hiroyuki Kagechika. Phosphineborane as a novel building block in drug discovery: structure-property and structure-activity relationships of 4-phosphinophenol derivatives. International conference on Phosphorous, Boron and Silicon 2023 2023.03.22

  2. Nao Namba, Tomomi Noguchi-Yachide, Yuichiro Matsumoto, Yuichi Hashimoto, Hiroyuki Kagechika, Shinya Fujii. Utilization of hydrophobic silyl functionalities for the structural development of liver X receptor (LXR) agonists. International conference on Phosphorous, Boron and Silicon 2023 2023.03.22

  3. Hiroyuki Kagechika, Shinya Fujii, Aya Tanatani. Development of Nuclear Receptor Ligands by Using Unique Hydrophobic Pharmacophore. The 8th SNU Symposium on Medicinal Chemistry 2023.01.13

  1. Takashi Murayama, Nagomi Kurebayashi, Ryosuke Ishida, Hiroyuki Kagechika. Reconstitution of depolarization-induced Ca2+ release platform for validation of skeletal muscle disease mutations and drug discovery. The 7th International Symposium on Biomedical Engineering 2022.11.25

  2. Yoshihiro Tada, Shuto Kawasaki, Hiroyuki Kagechika, Shinya Fujii. Structure-property relationship and PR antagonistic activity of N-phenylphosphinamide derivatives. The 7th International Symposium on Biomedical Engineering 2022.11.25

  3. Hiroyuki Baba, Tadashi Hosoya, Yuma Kondo, Saki Hatsuzawa, Ryosuke Ishida, Hiroyuki Kagechika, Shinsuke Yasuda. Anti-inflammatory effects of novel NF-κB inhibitory compounds in two inflammatory animal models. The 7th International Symposium on Biomedical Engineering 2022.11.25

  4. Ryosuke Ishida, Saki Haraoka, Shuichi Mori, Fumiaki Ando, Shinichi Uchida, Hiroyuki Kagechika. Development of small molecule inducing phosphorylation of perilipin for anti-obesity drug. The 7th International Symposium on Biomedical Engineering 2022.11.25

  5. Xi Zeng, Ryosuke Ishida, Nagomi Kurebayashi, Murayama Takashi, Yuuga Yamamoto, Shuichi Mori, Hiroyuki Kagechika. Development of novel RyR2 selective inhibitor. The 7th International Symposium on Biomedical Engineering 2022.11.25

  6. Saki Hatsuzawa, Ryosuke Ishida, Hiroyuki Baba, Tadashi Hosoya, Hiroyuki Kagechika. Development of novel immunosuppressive compounds leading anti-inflammatory effect. The 7th International Symposium on Biomedical Engineering 2022.11.25

  1. Kotaro Ochiai, Hiroyuki Kagechika, Shinya Fujii. Design, Synthesis and Evaluation of Novel Androgen Receptor Ligand Bearing Ferrocene as the Hydrophobic Pharmacophore. The 6th International Symposium on Biomedical Engineering (ISBE2021) 2021.12.02

  2. Shuichi Mori, Hiroto Iinuma, Takashi Murayama, Chin Xikun, Ryosuke Ishida, Nagomi Kurebayashi, Hiroyuki Kagechika. Structure development of ryanodine receptor 1(RyR1) inhibitor for activity and water-solubility. The 6th International Symposium on Biomedical Engineering (ISBE2021) 2021.12.02

  3. Nao Namba, Yuichiro Matsumoto, Yuichi Hashimoto, Tomomi Noguchi-Yachide, Hiroyuki Kagechika, Shinya Fujii. Structure Development of Silicon-Containing Derivatives of T0901317 as Novel Liver X Receptor (LXR) Ligands. The 6th International Symposium on Biomedical Engineering (ISBE2021) 2021.12.02

  4. Yoshihara S., Sasaki H., Kawasaki H., Yoshihara A., Masuno H., Kanda Y., Kagechika H, Tanatani A.. Structure-activity Relationship of Lithocholic Acid As Novel Nonsecosteroidal Vitamin D Derivatives. The 6th International Symposium on Biomedical Engineering (ISBE2021) 2021.12.02

  5. Nao Namba, Yuichiro Matsumoto, Yuichi Hashimoto, Tomomi Noguchi-Yachide, Hiroyuki Kagechika, Shinya Fujii. Development of Subtype-Selective Liver X Receptor (LXR) Ligands Using Silicon Functionalities. AFMC International Medicinal Chemistry Symposium 2021 2021.11.29

  6. Kotaro Ochiai, Hiroyuki Kagechika, Shinya Fujii. Development of Androgen Receptor Ligands Bearing Ferrocene as the Hydrophobic Pharmacophore. AFMC International Medicinal Chemistry Symposium 2021 2021.11.29

  7. Aya Tanatani, Chisaki Yoshioka, Hiroyuki Masuno, Nobutaka Numoto, Nobutoshi Ito, Hirata Naoya, Kanda Yasunari, Hiroyuki Kagechika. Development of Novel Lithocholic Acid Derivatives: Synthesis of Each Stereoisomer by Using Enzymatic Separation and The Vitamin D Activity. Symposium on Molecular Chirality 2021 2021.11.29 Hiroshima, Japan

  8. Yoshihara S., Sasaki H., Kawasaki H., Yoshihara A., Masuno H., Kanda Y., Kagechika H, Tanatani A.. Structure-activity relationship of Lithocholic Acid as Novel Nonsecosteroidal Vitamin D Derivatives. AFMC International Medicinal Chemistry Symposium 2021 2021.11.29

  1. Hiroyuki Kagechika. Development of Nuclear Receptor Ligands with Unique Pharmacophore. The 6th Joint Symposium between IBB/TMDU and Chulalongkorn University on Biomedical Materials and Engineering 2020.01.14

  1. 諸墨樹、森修一、影近弘之. カルボランを疎水性骨格として有する核内受容体LRH-1機能制御剤の創製. 日本薬学会第139年会 2019.03.20 東京

  1. Hiroyuki Kagechika, Shinya Fujii, Tomoya Hirano, Shinya Mori, Aya Tanatani. Development of Functional Molecules Based on Unique Scaffolds. EPFL/TMDU/UTokyo Joint Symposium 2018 2018.09.19 Lausanne, Switzland

  2. Tomoya Hirano, Chihiro Komatsu, Yuki Noji, Hiroyuki Kagechika. Development of photofunctional compounds that function under specific range of pH with “OFF-ON-OFF” type of change. Gordon Research Conference, Bioanalytical Sensors 2018.06.22 Newport, RI, USA

  3. Hidetomo Yokoo, Tomoya Hirano, Ayumi Ohsaki, Hiroyuki Kagechika. Development of novel environment-dependent fluorophore derived from fluorescent natural compounds. Gordon Research Conference, Bioanalytical Sensors 2018.06.22 Newport, RI, USA

  4. Soyoung Park, Junya Uchida, Ko Urushibara, Hiroyuki Kagechika, Takashi Kato, AyaTanatani. Self-assembly of Liquid-Crystalline Squaramides. 27th International Liquid Crystal Conference 2018.06.22 京都

  5. Hiroyuki Kagehcika. Development of Novel Synthetic Retinoids with Unique Hydrophobic Pharmacophore. FASEB meeting on retinoid 2018.06.10 Steamboat Springs, Corolado, USA

  6. Tsuyoshi Oikawa, Shinya Fujii, Hiroyuki Masuno, Emiko Kawachi, Hiroyuki Kagechika. Development of Novel Silyl-containing Retinoids. Symposium on Frontier of Genomic Medicine ‘Retinoid (Am80, Tamibarotene) as therapeutics for intractable diseases’ 2018.01.29 東京

  7. Mai Negishi, Hitomi Koga, Shuichi Mori, Hiroyuki Kagechika, Aya Tanatani. Development of Nitrogen-Containing Heteroaromatic Compounds as Novel Progesterone Antagonists. Symposium on Frontier of Genomic Medicine ‘Retinoid (Am80, Tamibarotene) as therapeutics for intractable diseases’ 2018.01.29 東京

  8. Yusuke Okazaki, Takashi Fujiwara, Asuka Takaguchi, Tomoya Hirano, Shuichi Mori, Hiroyuki Kagechika. Development of facile method to detect the activity of histone methyltransferase based on SNAr reaction. Symposium on Frontier of Genomic Medicine ‘Retinoid (Am80, Tamibarotene) as therapeutics for intractable diseases’ 2018.01.29 東京

  9. Nozomi Tsuemoto, Shuichi Mori, Emiko Kawachi, Hiroyuki Kagechika. Development of novel retinoids bearing pentafluorosulfanyl group. Symposium on Frontier of Genomic Medicine ‘Retinoid (Am80, Tamibarotene) as therapeutics for intractable diseases’ 2018.01.29 東京

  10. Haru Kawasaki, Harue Sasaki, Hiroyuki Masuno, Emiko Kawachi, Nobutoshi Ito, Hiroyuki Kagechika, Aya Tanatani. Development of Lithocholic Acid Derivatives with A 3-Hydroxyalky Group as Novel Nonsecosteroidal Vitamin D Analogs. Symposium on Frontier of Genomic Medicine ‘Retinoid (Am80, Tamibarotene) as therapeutics for intractable diseases’ 2018.01.29 東京

  11. Shuichi Mori, Ryohei Takagaki, Shinya Fujii, Aya Tanatani, Hiroyuki Kagechika. Development of novel progesterone receptor ligands bearing m-carborane as a hydrophobic pharmacophore. Symposium on Frontier of Genomic Medicine ‘Retinoid (Am80, Tamibarotene) as therapeutics for intractable diseases’ 2018.01.29 東京

  12. Mari Ishigami-Yuasa, Yuko Watanabe, Honoka Suzuyama, Hiroyuki Masuno, Shinya Fujii, Takayasu Mori, Eriko Kikuchi, Shinichi Uchida, Hiroyuki Kagechika. Development of WNK Signaling Inhibitors as a New Class of Antihypertensive Drugs. Symposium on Frontier of Genomic Medicine ‘Retinoid (Am80, Tamibarotene) as therapeutics for intractable diseases’ 2018.01.29 東京

  13. Tomoya Hirano, Michitake Hirano, Takashi Fujiwara, Takashi Umehara, Akihiro Ito, Minoru Yoshida, Hiroyuki Kagechika. Structural development of cyproheptadine as an inhibitor for histone methyltransfearse Set7/9. Symposium on Frontier of Genomic Medicine ‘Retinoid (Am80, Tamibarotene) as therapeutics for intractable diseases’ 2018.01.29 東京

  1. Aya Tanatani, Ko Urushibara, Mayumi Kudo, Shinya Fujii, Hyuma Masu, Isao Azumaya, Hiroyuki Kagechika. Helical Foldamers Based on the Conformational Properties of Aromatic Amides, Ureas and Squaramides. Chirality 2017/ISCD-29 2017.07.09 東京

  1. Kagechika, H.. Development of Functional Molecules with Unique Scaffolds. The 3rd Joint Symp. IBB/TMDU & Chulalongkorn Univ. Biomed. Mater. Engineer. 2016.12.15 Bangkok

  2. Rawangkan, A., Oya, Y., Iida, K., Kagechika, H., Shudo, K., Fujiki, H., Suganuma, M. . Innovative strategy of cancer treatment with the combination of Am80, a potent synthetic retinoid, and green tea catechin via down-regulation of　histone deacetylase 4, -5, and -6. Int. Symp. Biomed. Engineer. 2016.11.10 Tokyo

  3. Hirano, T., Noji, Y., Kato, D., Shiraishi, T., Kagechika, H.. Development of fluorescent sensors for microenvironemtal change. Int. Symp. Biomed. Engineer. 2016.11.10 Tokyo

  4. Mori, S., Takagaki, R., Fujii, S., Matsumura, M., Tanatani, A., Kagechika, H.. Development of m-carborane-based progesterone receptor ligands and their optical resolution by lipase reaction. Int. Symp. Biomed. Engineer. 2016.11.10 Tokyo

  5. Ishigam-Yuasa, M., Ekimoto, H., Kagechika, H.. Synergistic inhibition of several human cancer cell proliferations by a synthetic retinoid tamibarotene (Am80) in combination with the epigenetic modulators. Int. Symp. Biomed. Engineer. 2016.11.10 Tokyo

  6. Mori, S., Oshida, Y., Watanabe, Y., Yuasa, M., Kagechika, H.. Development of novel store-operated calcium entry inhibitors. Int. Chem. Biol. Symp 2016.10 Madison, USA

  7. Okazaki, Y., Fujiwara, T., Takaguchi, A., Hirano, T., Mori, S., Kagechika, H.. Development of a facile method to detect the activity of histone methyltransferase based on SNAr reaction. Int. Chem. Biol. Symp 2016.10 Madison, USA

  8. Tanatani, A., Tojo, Y., Urushibara, K., Yamamoto, S., Mori, H., Masu, H., Kudo, M., Hirano, T., Kagechika, H.. N-Alkylated Pyrroleamide Oligomers with Folded Cis-Amide Conformation. Symposium on Foldamers 2016 2016.09.26 Bordeaux-Pessac, France

  9. Hirano, T., Shiraishi, T., Noji, Y., Kato, D., Kagechika, H.. Development of fluorescent sensors for microenvironmental change based on fluorescent compounds library. 252nd ACS National Meeting 2016.08 Philadelphia, USA

  10. Yokoo, H., Hirano, T., Ohsaki, A., Kagechika, H.. Development of Novel Fluorescent Sensors Based on Fluorescent Natural Compounds. 252nd ACS National Meeting 2016.08 Philadelphia, USA

  11. Kagehcika, H.. Development of novel retinoids with unique hydrophobic pharmacophore. FASEB meeting on retinoid 2016.06.20 Florida, USA

  12. Hirano, T., Hirano, M., Fujiwara, T., Ohira, K., Ito, A., Yoshida, M., Kagechika, H. . Structure-activity relationships of cyroheptadine as inhibitors of histone methyltransferase, Set7/9. International symposium for RIKEN epigenetics program 2016.02 Tokyo

  13. Mori, S., Okazaki, Y., Fujiwara, T., Takaguchi, A., Hirano, T., Kagechika, H.. Development of novel assay methods for detection of N-monomethylated lysine using SNAr reaction. International symposium for RIKEN epigenetics program, 2016.02 Tokyo

  1. Shiraishi, T., Hirano, T., Noji, Y., Saito, T., Kagechika, H.. Development of various fluorescent sensors based on coumarin scaffold. Pacifichem 2015 2015.12.15 Hawaii, USA

  2. Yuasa, M., Mori, T., Fujii, S., Watanabe, Y., Suzuyama, H., Kikuchi, E., Uchida, S., Kagechika, H.. Development of WNK signaling inhibitors as new class of antihypertensive drugs. Pacifichem 2015 2015.12.15 Hawaii, USA

  3. Ainiwaer, D., Ito, S., Nakagawa, K., Zeyu, Y., Yuasa, M., Hata, Y., Kagechika, H.. Development of novel activators for transcriptional co-activator TAZ involved in Hippo pathway. Pacifichem 2015 2015.12.15 Hawaii, USA

  4. Mori, S., Takagaki, R., Fujii, S., Matsumura, M., Tanatani, A., Kagechika, H.. Development of m-carborane-based progesterone receptor ligands and their optical resolution by lipase-catalyzed reaction. 3rd International conference on retinoid 2015.10.21 Gifu, Japan

  5. Hirano, M., Hirano, T., Fujiwara, T., Ohira, K., Kagechika, H., Ito, A., Yoshida, M.. Study for the development of inhibitors for Set7/9. 3rd International conference on retinoid 2015.10.21 Gifu, Japan

  6. Oya, Y., Suganuma, M., Iida, K., Sakai, R., Kagechika, H., Shudo, K., Fujiki, H. . Combination of EGCG and Am80 is an innovative cancer treatment mediated through induction of GADD153 and DR5 gene expressions caused by inhibition of histone deacetylase 4 and 5. 3rd International conference on retinoid 2015.10.21 Gifu, Japan

  7. Fukasawa, H., Shudo, K., Kagechika, H.. Therapeutic potential of tamibarotene for Alzheimer's disease and COPD. 3rd International conference on retinoid 2015.10.21 Gifu, Japan

  8. Ishigami-Yuasa, M., Ekimoto, H., Kagechika, H.. Synergistic inhibition of viable human cancer cells by a synthetic retinoid tamibarotene (Am80) in combination with DNA methyltransferase or histone deacetylase inhibitors. 3rd International conference on retinoid 2015.10.21 Gifu, Japan

  9. Kagechika, H., Fujii, S., Shirakawa, H., Komai, M., Qin, X.-Y., Kojma, S.. Systematic synthesis and biological activities of ω-carboxylated menaquinone derivatives.. FASEB meeting on vitamin K 2015.06.12 Chicago, USA

  10. Masuno, H., Fujii, S., Hirano, T.; Kawachi, E.; Tanatani, A.; Kagechika, H.. Development of carborane-based non-secosteroidal vitamin D analogs. 18th Workshop on Vitamin D 2015.04.21 Delft, Nederland

  1. Tomoya Hirano, Takuya Shiraishi, Toshiki Saito, Hiroyuki Kagechika. Development of Fluorescent Sensors with its Functions Regulated by Chemical or Enzymatic Reaction. 3rd Intrnational Chemical Biology Meeting 2014.11 San Francisco, USA

  2. Shuichi Mori, Ryohei Takagaki, Shinya Fujii, Mio Matsumura, Aya Tanatani, Hiroyuki Kagechika. Lipase-catalyzed optical resolution and biological activity of boron-cluster-based progesterone receptor ligands. 3rd Intrnational Chemical Biology Meeting 2014.11 San Francisco, USA

  3. Hiroyuki Kagechika, Eiichi Nakano, Ayumi Yamada, Yuki Takeuchi, Shuichi Mori, Hiroyuki Masuno, Shinya Fujii. Design and Synthesis of C,C’-Diphenylcarborane Derivatives as Novel Progesterone Receptor Antagonists. IMEBoron XV 2014.08 Prague, Czech Republic

  4. Shigeru Ito, Kentaro Nakagawa, Zeyu Yang, Mari Yuasa, Yutaka Hata, Hiroyuki Kagechika. Investigation of regulatory compounds toward transcriptional co-activator TAZ. EMBO Conference Series: Chemical Biology 2014 2014.08 Heidelberg, Germany

  5. Shinya Fujii, Shotaro Iihama, Hiroyuki Kagechika. Synthesis and Characterization of Novel m-Ccarborane-Containing Porphyrinoid. IMEBoron XV 2014.08 Prague, Czech Republic

  6. Mari Yuasa, Shuichi Mori, Yohei Watanabe, Hiroyuki Kagechika. Novel　Store-Operated Calcium Entry (SOCE) inhibitors having the retinoid-like structure. FASEB 2nd International retinoid meeting 2014.06.05 Chicago, USA

  7. Hiroyuki Kagechika. Development of Novel Synthetic Retinoids with Unique Hydrophobic Core Structure. FASEB 2nd International retinoid meeting 2014.06.05 Chicago, USA

  8. Synthesis of novel retinoid and relsated compounds. 2014.12.05 Kyoto, Japan

  9. Shuichi Mori, Ryohei Takagaki, Shinya Fujii, Mio Matsumura, Aya Tanatani, and Hiroyuki Kagechika. Lipase-catalyzed asymmetric acylation of boron cluster-containing secondary alcohols. Active Enzyme Molecule 2014 2014.12 Toyama, Japan

  10. Hitomi Koga, Marie Kinoshita, Shinya Fujii, Hiroyuki Kagechika, Aya Tanatani. Development of AR antagonists based on coumarin skeleton. 2014.11.27 Kobe, Japan

  11. Yumeto Yamauchi, Shinya Fujii, Hiroyuki Masuno, Emiko Kawachi, Hiroyuki Kagechika. Development of silanol derivatives with AR antagonistic activity. 2014.11.27 Kobe, Japan

  12. Honoka Suzuyama, Yuko Watanabe, Takayasu Mori, Eriko Kikuchi, Mari Yuasa, Shinya Fujii, Shinichi Uchida, Hiroyuki Kagechika. Development of novel inhibitors of WNK signaling. 2014.11.27 Kobe, Japan

  13. DILiHUMAER AINIWAER, Shigeru Ito, Kentaro Nakagawa, Zeyu Yang, Mari Yuasa, Yutaka Hata, Hiroyuki Kagechika. Development of novel TAZ modulators in Hippo signaling. 2014.11.27 Kobe, Japan

  14. Syuichi Mori, Yohei Watanabe, Yuki Oshida, Mari Yuasa, Hiroyuki Kagechika. Development of novel SOCE modulators. 2014.11.27 Kobe, Japan

  15. Hitomi Koga, Marie Kinoshita, Shinya Fujii, Hiroyuki Kagechika, Aya Tanatani. Development of AR antagonists bearing coumarin moiety. 2014.10.08 Akita, Japan

  16. Yumeto Yamauchi, Shinya Fujii, Emiko Kawachi, Hiroyuki Masuno, Hiroyuki Kagechika. Development of AR antagonists bearing silanol functionality. 2014.10.08 Akita, Japan

  17. Syuichi Mori, Mari Yuasa, Yohei Watanabe, Yuki Oshida, Hiroyuki Kagechika. Inhibition of SOCE by synthetic retinoids. 2014.10.08 Akita, Japan

  18. Tomoya Hirano, Takuya Shiraishi, Toshiki Saito, Hiroyuki Kagechika. Development of multi-functional fluorescent sendors based on fluorescent molecule library. 2014.09 Okayama, Japan

  19. Shinya Fujii, Kenji Hatta, Hiroyuki Masuno, Emiko Kawachi, Hiroyuki Kagechika. Development of nonsecosteroidal vitamin D analogs. 2014.06.14 Himeji, Japan

  20. Shinya Fujii, Ayumi Yamada, Shuichi Mori, Hiroyuki Kagechika. Development of novel PR antagonists based on the structure of curcumin. 2014.06 Osaka, Japan

  21. Tomoya Hirano, Takuya Shiraishi, Toshiki Saito, Hiroyuki Kagechika. Development of fluorescent sensors based on Fluorescent molecule library. 2014.06 Osaka, Japan

  22. Shigeru Ito, Kentaro Nakagawa, Zeyu Yang, Mari Yuasa, Hiroyuki Kagechika, Yutaka Hata. Development of modulators of TAZ. 2014.06 Osaka, Japan

  23. Syuichi Mori, Yohei Watanabe, Mari Yuasa, Hiroyuki Kagechika. Novel Store-Operated Calcium Entry (SOCE) inhibitors. 2014.06 Osaka, Japan

  24. Takashi Fujiwara, Asuka Takaguchi, Syuichi Mori, Tomoya Hirano, Hiroyuki Kagechika. Development of screening method for histone methyl transferase activity. 2014.03 Nagoya, Japan

  25. Yohei Watanabe, Syuichi Mori, Mari Yuasa, Hiroyuki Kagechika. Development of novel Ca modulators. 2014.03 Kumamoto, Japan

  26. Kenji Hatta, Emiko Kawachi, Hiroyuki Masuno, Fujii Shinya, Hiroyuki Kagechika. Development of novel vitamin D analogs with carborane moiety. 2014.03 Kumamoto, Japan

  27. Toshiki Saito, Takuya Shiraishi, Tomoya Hirano, Hiroyuki Kagechika. Development of novel fluorescent sensors whose functions change by Click reaction. 2014.03 Kumamoto, Japan

  28. Takuya Shiraishi, Tomoya Hirano, Takashi Fujiwara, Hiroyuki Kagechika. Development of Fluorescent ligands for estrogen receptors. 2014.03 Kumamoto, Japan

To the head of this page.▲